Arkolith/Insider Trading/KYTX/Form 4

Jones Ryan Alexander

Chief Financial OfficerKyverna Therapeutics, Inc. (KYTX) · full profile →Form 4 · filed May 29, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2024Option exercise(M)11K$0.73$8K37K
May 28, 2024Option exercise(M)7K$0.73$5K44K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2024Option exercise(M)11K—$00
May 28, 2024Option exercise(M)7K—$02K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-065983) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Kyverna Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp